In contrast, IL-33 was detectable in 58.5%, 42.4%, 46.8% and 43.6% of individuals without CAD, patients with SA, NSTEMI and STEMI, respectively (p = NS) and IL-33 serum levels did not differ between the respective groups (p = NS, Figure 1B). Here, IL33 is linked to coronary artery disorder.